Related Experiment Video
Updated: Jul 25, 2026

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
Premature aging and neuropathic behaviours induced by an acute low-dose exposure to a sarin surrogate
Alexandre Champault1, Sarah Leterrier2, Rosalie Bel3
1Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, Bretigny sur Orge, France; Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), CEA, CNRS, Inserm, Université Paris-Saclay, Service Hospitalier Frédéric Joliot, Orsay, France.
Abstract:
Acute poisoning from organophosphorus (OP) compounds induced a cholinergic toxidrome. Neurological complications may manifest weeks after the initial exposure, including muscle weakness and progressive loss of sensitivity. These symptoms may be analogous to those observed in elderly individuals. However, the delayed neurological impact of OP exposure has received limited attention and remains an under-explored area of research. The present study investigated the long-term effects of OP exposure on the sensorimotor system using a mouse model exposed to a sublethal dose of a sarin surrogate. The mice received a 0.5 LD50 dose of 4-nitrophenyl isopropylmethylphosphonate (NIMP), and were observed for a period of six months. Our results demonstrate that NIMP exposure induced a mild intoxication severity in mice, without affecting weight evolution. Behavioral evaluation, using locomotor and sensory tests, revealed that mice exhibited persistent muscle weakness and an increase in mechanical sensitivity. Six months after NIMP exposure, acetylcholinesterase activity remained inhibited in specific regions of the cerebral cortex, while the spinal cord exhibited a return to normal values. Positron emission tomography scans and microcomputed tomography imaging revealed alterations in cerebral glucose metabolism and bone density. Luminex multiplex immunoassay analyses revealed an increase in specific biomarkers of aging. The present study demonstrates that a sublethal dose of NIMP triggered premature aging phenotype, resulting in long-term sensorimotor impairments, neurometabolic and cellular disturbances. These findings underscore the importance of identifying intoxication hallmarks, even in cases of asymptomatic OP exposure.
Insights
Organophosphorus (OP) compound exposure, even at sublethal doses, can cause premature aging and long-term sensorimotor deficits in mice. This highlights the need to identify subtle intoxication signs for early intervention.
Area of Science:
- Neuroscience
- Toxicology
- Aging Research
Background:
- Organophosphorus (OP) compounds can cause acute cholinergic toxidrome.
- Delayed neurological effects, like muscle weakness and sensory loss, are under-explored.
- These symptoms resemble those in elderly individuals.
Purpose of the Study:
- Investigate long-term sensorimotor effects of sublethal OP exposure.
- Utilize a mouse model exposed to a sarin surrogate (NIMP).
- Assess neurological, metabolic, and cellular changes over six months.
Main Methods:
- Administered a 0.5 LD50 dose of 4-nitrophenyl isopropylmethylphosphonate (NIMP) to mice.
- Conducted behavioral tests for locomotor and sensory function.
- Measured acetylcholinesterase activity, performed PET and microCT scans, and used Luminex assays.
Main Results:
- NIMP exposure caused mild intoxication without affecting weight.
- Mice showed persistent muscle weakness and increased mechanical sensitivity.
- Long-term effects included inhibited cortical acetylcholinesterase, altered brain metabolism, reduced bone density, and increased aging biomarkers.
Conclusions:
- Sublethal NIMP exposure induces a premature aging phenotype in mice.
- This leads to lasting sensorimotor impairments and neurometabolic disturbances.
- Early identification of OP intoxication hallmarks is crucial, even in asymptomatic cases.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

